GlassScriptPhysician profile
Nizar Issa
NPI 1609096577
$4,268.89
in general payments reported to CMS, 2019-2025
18 companies · $802 in 2025
The $802 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $495 · 2021: $637 · 2022: $726 · 2023: $558 · 2024: $611 · 2025: $802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,971.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,971.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,975.53 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $911.58 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Sunovion Pharmaceuticals INC. | $210.44 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $207.68 | 2019-2023 | Stiolto Respimat |
| Mylan Specialty L.P. | $206.06 | 2019-2024 | Yupelri |
| Viatris Specialty LLC | $192.25 | 2025 | Yupelri |
| Harmony Biosciences LLC | $160.46 | 2023-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $122.21 | 2025 | |
| Philips North America LLC | $70.57 | 2021-2025 | Vest Therapy Und |
| Insmed, INC. | $49.00 | 2021-2025 | Arikayce |
| Electromed, INC. | $36.47 | 2025 | Smartvest |
| Circassia INC. | $28.37 | 2019 | |
| Alexion Pharmaceuticals, INC. | $20.29 | 2022 | |
| Fisher & Paykel Healthcare INC | $17.11 | 2022 | |
| Mallinckrodt Hospital Products INC. | $16.69 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $15.75 | 2025 | Ohtuvayre |
| Pulmonx Corporation | $14.59 | 2023 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Grifols USA, LLC | $13.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nizar Issa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.